XAF1 and cancer: Given that loss or reduction of XAF1 expression by aberrant promoter hypermethylation is common in human cancers, our data support that epigenetic silencing of XAF1 is a mechanism leading to abnormal elevation of GRP78 and tumor resistance to ER stress.